MedMira Inc.
MMIRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$42.1M
Close$
$-0.01
128.9% downside
Current Fair Value
128.9% downsideOvervalued by 128.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $42.10 Million |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $0 |
| Beta | 0.76 |
| Outstanding Shares | 697,666,127 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -13.64 |
|---|---|
| PEG | 26.82 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About MedMira Inc.
52 employees
CEO: Hermes Chan
MedMira Inc. is a biotechnology company focused on the research, development, manufacturing, and global commercialization of rapid diagnostic solutions and related technology platforms. Its operations span North America, Europe, the Asia...